10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
62.65
-0.57 (-0.90%)
At close: Sep 4, 2026, 4:00 PM EDT
62.39
-0.26 (-0.42%)
After-hours: Sep 4, 2026, 7:30 PM EDT
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $8.16 billion as of September 4, 2026. Its market cap has increased by 391.52% in one year.
Market Cap
8.16B
Enterprise Value
7.69B
1-Year Change
391.52%
Ranking
Category
Stock Price
$62.65
ChartMarket Cap Chart
Since September 12, 2019, 10x Genomics's market cap has increased from $4.95B to $8.16B, an increase of 64.88%. That is a compound annual growth rate of 7.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 8.16B | 295.47% |
| Dec 31, 2025 | 2.06B | 18.74% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veeva Systems | 44.90B |
| BrightSpring Health Services | 12.80B |
| Tempus AI | 11.56B |
| HealthEquity | 7.96B |
| Hinge Health | 7.39B |
| Waystar Holding | 4.85B |
| Doximity | 4.74B |
| HeartFlow | 4.30B |